SeaLife Pharma's Management

Chief Executive Officer (CEO)

Mag. Dr. Alexander Pretsch, BSc.

Dr. Pretsch has been CEO of the Company since its foundation in 2008. Dr. Pretsch is a marine biologist, biomedicine and biotechnologist with focus on infection diseases. He has more than 20 years of experience in researching marine organism with academically and industrial background. He gained significant development experience as co-founder and management member of other biotech-companies. He is the legal representative of SLP and responsible for general administration and investor relations.
(Photo: right)

Chief Finance Officer & Chief Operations Officer

Ing. Andreas Krems MBA

Andreas Krems holds a degree in Executive Sales Management and has a business management history spanning over 20 years in various industries. His background in counseling and consultancy led to various operative roles including General Management in the financial and technical industry and a track record as company founder. Mr. Krems is co-founder of Sealife, legal representative and responsible for Finance
and Administration.
(Photo: left)

Chief Scientific Officer (CSO)

Prof. Dr. Christoph Wiesner

Prof. Dr. Christoph Wiesner has a long-standing expertise in basic, applied and clinical research. He exceedingly built up core competences in the development of novel cell-based and organotypic test systems for drug screening. Dr. Wiesner is cell- and molecular- biologist and has an extensive publication record in the area of cell biology, tissue engineering and oncology. As Sealife`s CSO he is responsible for the scientific development of the company.